Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)

Market Cap	24.13B +56.6%
Revenue (ttm)	613.24M +114.2%
Net Income	-277.82M
EPS	-0.27
Shares Out	1.03B
PE Ratio	n/a
Forward PE	254.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,467,310
Open	24.30
Previous Close	24.24
Day's Range	22.92 - 24.30
52-Week Range	15.14 - 35.34
Beta	1.47
Analysts	Strong Buy
Price Target	37.45 (+60.04%)
Earnings Date	Aug 28, 2026

About HKG:2252

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People’s Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR’obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 464
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2252

Financial Performance

In 2025, HKG:2252's revenue was 551.07 million, an increase of 114.22% compared to the previous year's 257.25 million. Losses were -249.66 million, -61.14% less than in 2024.

Financial numbers in CNY

Analyst Summary

According to 9 analysts, the average rating for 2252 stock is "Strong Buy." The 12-month stock price target is $37.45, which is an increase of 60.04% from the latest price.

Price Target

$37.45

(60.04% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error